Hemophilia treatment center, Ohio, calendar year 2025. Everything below is as the workbook stored it, with figures shown to the cent. Each section follows the Ohio Department of Health's template, in its order and words.
The name is HRSA's, from its public list of covered entities read on 11 November 2026. The workbook prints the 340B ID and no name.
Drugs the covered entity dispensed through its own pharmacies.
Drugs dispensed in house, as stored, for NATIONWIDE CHILDREN'S HOSPITAL (HEMOSTASIS & THROMBOSIS CENTER) (HM43205)
Row of the template
Commercial Insurance/Private Insurance
Medicare
Medicaid (all states)
Other Third-Party Payor
Uninsured/Self-Pay
Total
Acquisition costAggregate Acquisition Cost for all 340B drugs dispensed by the Covered Entity
$6,342,184
$0
$8,091,289
$1,406,717
$0
$15,840,190
Payments receivedAggregate Payments Received for all 340B drugs dispensed by the Covered Entity
$8,312,489
$0
$11,024,901
$2,370,963
$0
$21,708,353
All prescriptionsTotal number of Prescriptions dispensed by the Covered Entity (340B and non-340B)
191
0
369
75
0
635
340B prescriptionsTotal number of Prescriptions dispensed by the Covered Entity (340B)
191
0
369
75
0
635
Percentage that were 340BPercentage of total prescriptions that were 340B
100%
#DIV/0!
100%
100%
#DIV/0!
100%
Drugs dispensed through contract pharmacies
Drugs contract pharmacies dispensed on behalf of the covered entity.
Drugs dispensed through contract pharmacies, as stored, for NATIONWIDE CHILDREN'S HOSPITAL (HEMOSTASIS & THROMBOSIS CENTER) (HM43205)
Row of the template
Commercial Insurance/Private Insurance
Medicare
Medicaid (all states)
Other Third-Party Payor
Uninsured/Self-Pay
Indeterminate (Explain)
Total
Acquisition costAggregate Acquisition Cost for all 340B drugs dispensed by all Contract Pharmacies on behalf of the Covered Entity above:
N/A
N/A
N/A
N/A
N/A
N/A
$0
Payments receivedAggregate Payments Received for all 340B drugs dispensed by all Contract Pharmacies on behalf of the Covered Entity above:
N/A
N/A
N/A
N/A
N/A
N/A
$0
All prescriptionsTotal number of Prescriptions filled by all Contract Pharmacies on behalf of the Covered Entity (340B and non-340B):
N/A
N/A
N/A
N/A
N/A
N/A
0
340B prescriptionsTotal number of 340B Prescriptions filled by all Contract Pharmacies on behalf of the Covered Entity:
N/A
N/A
N/A
N/A
N/A
N/A
0
Percentage that were 340BPercentage of total Covered-Entity associated prescriptions that were 340B:
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#DIV/0!
Drugs administered
Drugs the covered entity administered, for example by infusion or injection.
Drugs administered, as stored, for NATIONWIDE CHILDREN'S HOSPITAL (HEMOSTASIS & THROMBOSIS CENTER) (HM43205)
Row of the template
Commercial Insurance/Private Insurance
Medicare
Medicaid (all states)
Other Third-Party Payor
Uninsured/Self-Pay
Total
Acquisition costAggregate Acquisition Cost for all 340B drugs administered by the Covered Entity
N/A
N/A
N/A
N/A
N/A
$0
Actual paymentsAggregate Payments Received for all 340B drugs administered by the Covered Entity - Actual Payments
N/A
N/A
N/A
N/A
N/A
$0
Estimated paymentsAggregate Payments Received for all 340B drugs administered by the Covered Entity - Estimated Payments*
N/A
N/A
N/A
N/A
N/A
$0
Total paymentsAggregate Payments Received for all 340B drugs administered by the Covered Entity - TOTAL
N/A
N/A
N/A
N/A
N/A
$0
All prescriptionsTotal number of Prescriptions administered by the Covered Entity (340B and non-340B)
N/A
N/A
N/A
N/A
N/A
0
340B prescriptionsTotal number of Prescriptions administered by the Covered Entity (340B)
N/A
N/A
N/A
N/A
N/A
0
Percentage that were 340BPercentage of total prescriptions that were 340B
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#DIV/0!
Figures are shown to the cent. The downloads keep each figure exactly as it is written in the file, and the cell file lists the workbook cell each one was read from.
Costs of running the program
Amounts in US dollars, as the workbook stores them.
Costs, as stored, for NATIONWIDE CHILDREN'S HOSPITAL (HEMOSTASIS & THROMBOSIS CENTER) (HM43205)
Cost
Amount
Cell
Contract pharmacies
$3,797,549
(Note: These are payments to in-house pharmacy, given there is no dedicated in-house pharmacy field)
C46
Third-party administrators
$0
C47
Consultants
$4,250
C48
Software and IT
$0
C49
Other outside costs
$63,253
C50
Staffing
$1,122,412
C53
Internal IT
$0
C54
Other internal costs
$717
C55
Contract pharmacies
Number of contract pharmacies as typed
0
Explanation of the Indeterminate column, as typed
N/A
Uses of 340B funds
What the filer typed under the template's questions about how it uses the money 340B brings in. A dash or an empty cell is left out.
Uses of 340B funds, as typed, for NATIONWIDE CHILDREN'S HOSPITAL (HEMOSTASIS & THROMBOSIS CENTER) (HM43205)
Kind
Description
Amount
Cell
Program or service
See #24
See #24
C65
Program or service
See #24
See #24
C66
Program or service
See #24
See #24
C67
Program or service
See #24
See #24
C68
Program or service
See #24
See #24
C69
Item
N/A
$0
C72
Item
N/A
$0
C73
Item
N/A
$0
C74
Item
N/A
$0
C75
Item
N/A
$0
C76
Other use
N/A
$0
C78
Narrative, as typed
N/A
Narrative given where the entity cannot detail its uses, as typed
Note on #2 above - the NPIs of our hematology providers are included above. NPIs of our oncology and BMT physicans can also be provided on request (limited space in collection tool).
Introduction:
The 340B Drug Pricing Program intends to enable covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. For Nationwide Children's, this program is critical to supporting our mission of providing the highest quality of care to all children and their families, regardless of their ability to pay. The 340B savings achieved through our Hemostasis and Thrombosis Center are reinvested directly into care and advocacy for our patient population.
Comprehensive Care Model:
Through 340B savings, the Hemostasis and Thrombosis Center at Nationwide Children’s Hospital is able to offer a comprehensive care model that serves as a one-stop-shop for patients and families with bleeding and clotting disorders. This model includes a multidisciplinary team of physicians, nurse practitioners, nurse clinicians, nurses, genetic counselors, psychologists, pharmacists, dental hygienists, psychologists, among others. These disciplines work collaboratively to ensure the best possible outcomes and experience for patients and their families.
Additionally, Nationwide Children’s is home to one of the oldest Young Women’s Hematology clinics in the country, combining expertise in hemostasis-thrombosis and adolescent medicine. This specialized clinic provides a compassionate, patient-centered approach for adolescent girls with suspected bleeding and clotting disorders and offers advanced diagnostic and treatment options for those experiencing heavy menstrual bleeding.
Professional Education and Training:
The education and development of hemostasis and thrombosis experts is also a top priority. Nationwide Children’s Hospital offers a fourth-year fellowship for physicians seeking to expand their expertise in hemostasis and thrombosis, helping to address a growing workforce shortage of adequately trained physicians in this field. Fellows complete a comprehensive curriculum including, outpatient clinical care, inpatient service, research, quality improvement, teaching opportunities, and select elective rotations.
Research:
Research is a central focus of the Hemostasis and Thrombosis Center at Nationwide Children’s. HTC funds are currently being reserved for a research study evaluating a new treatment for rare congenital bleeding disorders. The study aims to assess the effectiveness of a drug in mice that blocks a protein responsible for slowing down blood clotting. By blocking this protein, the body can produce more thrombin, a key enzyme that helps blood clot. If successful in mice, this research could lead to a new treatment option for individuals with rare congenital bleeding disorders, potentially reducing the need for therapies that require blood transfusions. This project is currently under review by HRSA.
Laboratory Medicine:
The Hemostasis and Thrombosis Center at Nationwide Children’s Hospital has invested in a Director of Hemostasis and Thrombosis Testing within the Division of Pathology and Laboratory Medicine. This position is responsible for reviewing and interpreting lab tests related to bleeding and clotting conditions, diagnosing new cases of hemophilia, identifying other congenital or acquired coagulopathies, detecting and quantifying acquired inhibitors, and advising on approaches to multiple factor concentrate monitoring. The role also includes interpretation of platelet function testing and the detection and diagnosis of both acquired and congenital thrombophilia. Additionally, the Director collaborates closely with hematology physician partners to assess the feasibility of introducing new laboratory tests.
This role also has an important teaching component, providing education to residents and fellows on laboratory administration, how lab tests for bleeding and clotting work, how medications that affect clotting are monitored, and how lab results guide decisions about blood transfusions and patient treatment.
Community Outreach and Education:
The Hemostasis and Thrombosis Center at Nationwide Children’s is a recipient of a grant from the CASCADE Hemophilia Consortium, enabling the Center to provide additional support to patients and families in need. This includes assistance with medical expenses, transportation, among other items.
Nationwide Children’s also hosts a Family Education Day at the Columbus Zoo for patients with bleeding disorders and their families. This event covers a wide range of topics, including infusion education, mental health, genetics, and transitioning from pediatric to adult healthcare providers. Additional sessions address school-related concerns, finding additional community resources, available hemophilia camps for children and young adults, and navigating health insurance.
School outreach is another key priority. The Hemophilia and Thrombosis Center team provides education to daycare, preschool, and school staff on hemophilia and strategies to support students with bleeding disorders in educational settings.
Our staff also partner with the Greater Ohio Bleeding Disorders Foundation, providing community education at local events.
Finally, Nationwide Children’s supports FAMOHIO, an organization that hosts an Education Weekend for individuals and families affected by bleeding disorders.
The filer in the workbook
340B ID as typed
HM43205
NPIs as typed
1184829301
1194756049
1205125887
1679552392
1760576300
1548247406
1912192535
1780941393
1790179943
1306868740
1477927598
1427799287
1932621653
1336935030
1023214673
1164950697
1396730073
1922553296
Differences in this workbook
No difference was found between this workbook's own figures by the rules in Methods.
Two separate programs read each cell of the workbook, and a value is kept when their reads agree. The cells of this workbook are listed one by one in the dataset repository.